WACHSTUM UND WACHSTUMSSTORUNGEN VON KINDERN NACH THERAPIE EINES MEDULLOBLASTOMS

A. Koch; H. G. Dorr; R. Beyer; J. Erhardt; R. Fahlbusch; J. Dunst; J. D. Beck

WACHSTUM UND WACHSTUMSSTORUNGEN VON KINDERN NACH THERAPIE EINES MEDULLOBLASTOMS

Translated title of the contribution: Growth and growth disorders in children treated for medulloblastoma

A. Koch^*, H. G. Dorr, R. Beyer, J. Erhardt, R. Fahlbusch, J. Dunst, J. D. Beck

^*Corresponding author for this work

Department of Radiotherapy

University of Erlangen–Nuremberg

4 Citations (Scopus)

Abstract

Growth disorders in children treated for medulloblastoma are one of the commonest late sequelae and are mainly caused by growth hormone deficiency, which occurs within a few years in almost all patients following cranial irradiation. We report on 16 children treated and followed-up in our hospital. The data were analyzed retrospectively. A decrease in growth was observed in all patients after tumour therapy. 5 patients have reached their final height, which is definitely lower than the normal adult height and their individual target height. Growth hormone deficiency was diagnosed in 11 patients. Standardized endocrinological follow-up programs have to be established to allow for an early diagnosis of endocrine disorders and the begin of adequate therapy in time.

Translated title of the contribution	Growth and growth disorders in children treated for medulloblastoma
Original language	German
Journal	Monatsschrift fur Kinderheilkunde
Volume	142
Issue number	11
Pages (from-to)	884-889
Number of pages	6
ISSN	0026-9298
Publication status	Published - 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{ebb9d3e4116c4ddf97268b74597d42f9,

title = "WACHSTUM UND WACHSTUMSSTORUNGEN VON KINDERN NACH THERAPIE EINES MEDULLOBLASTOMS",

abstract = "Growth disorders in children treated for medulloblastoma are one of the commonest late sequelae and are mainly caused by growth hormone deficiency, which occurs within a few years in almost all patients following cranial irradiation. We report on 16 children treated and followed-up in our hospital. The data were analyzed retrospectively. A decrease in growth was observed in all patients after tumour therapy. 5 patients have reached their final height, which is definitely lower than the normal adult height and their individual target height. Growth hormone deficiency was diagnosed in 11 patients. Standardized endocrinological follow-up programs have to be established to allow for an early diagnosis of endocrine disorders and the begin of adequate therapy in time.",

author = "A. Koch and Dorr, \{H. G.\} and R. Beyer and J. Erhardt and R. Fahlbusch and J. Dunst and Beck, \{J. D.\}",

year = "1994",

language = "Deutsch",

volume = "142",

pages = "884--889",

journal = "Monatsschrift fur Kinderheilkunde",

issn = "0026-9298",

number = "11",

}

TY - JOUR

T1 - WACHSTUM UND WACHSTUMSSTORUNGEN VON KINDERN NACH THERAPIE EINES MEDULLOBLASTOMS

AU - Koch, A.

AU - Dorr, H. G.

AU - Beyer, R.

AU - Erhardt, J.

AU - Fahlbusch, R.

AU - Dunst, J.

AU - Beck, J. D.

PY - 1994

Y1 - 1994

N2 - Growth disorders in children treated for medulloblastoma are one of the commonest late sequelae and are mainly caused by growth hormone deficiency, which occurs within a few years in almost all patients following cranial irradiation. We report on 16 children treated and followed-up in our hospital. The data were analyzed retrospectively. A decrease in growth was observed in all patients after tumour therapy. 5 patients have reached their final height, which is definitely lower than the normal adult height and their individual target height. Growth hormone deficiency was diagnosed in 11 patients. Standardized endocrinological follow-up programs have to be established to allow for an early diagnosis of endocrine disorders and the begin of adequate therapy in time.

AB - Growth disorders in children treated for medulloblastoma are one of the commonest late sequelae and are mainly caused by growth hormone deficiency, which occurs within a few years in almost all patients following cranial irradiation. We report on 16 children treated and followed-up in our hospital. The data were analyzed retrospectively. A decrease in growth was observed in all patients after tumour therapy. 5 patients have reached their final height, which is definitely lower than the normal adult height and their individual target height. Growth hormone deficiency was diagnosed in 11 patients. Standardized endocrinological follow-up programs have to be established to allow for an early diagnosis of endocrine disorders and the begin of adequate therapy in time.

UR - https://www.scopus.com/pages/publications/0027971775

M3 - Zeitschriftenaufsätze

AN - SCOPUS:0027971775

SN - 0026-9298

VL - 142

SP - 884

EP - 889

JO - Monatsschrift fur Kinderheilkunde

JF - Monatsschrift fur Kinderheilkunde

IS - 11

ER -

WACHSTUM UND WACHSTUMSSTORUNGEN VON KINDERN NACH THERAPIE EINES MEDULLOBLASTOMS

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this